Barcelona based Biorce secured 43.8 million Euro in Series A funding to scale its Aika AI platform.
The AMW Read
This provides an incremental update on a new player in the vertical AI healthcare/bio space via a standard Series A funding event that does not meet the $500M threshold for cross.§D.
NoveltySignificance
Healthcare & Bio · Player Map
Barcelona based Biorce secured 43.8 million Euro in Series A funding to scale its Aika AI platform. By leveraging 1 million trials, the system aims to slash trial costs and timelines by 50 percent, addressing the protocol amendments that delay 57 percent of studies. This reflects a systemic shift toward regulatory-ready, human-in-the-loop AI models. The U.S. expansion underscores a transition toward global data driven pharmaceutical efficiency. 🚀
